SLC44A2
Choline transporter-like protein 2
Also known as: CTL2, CTL2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IWA5
- Gene
- SLC44A2
- Ensembl
- ENSG00000129353
- Chromosome
- 19
- Canonical length
- 706 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Vesicles,Cell Junctions
OverviewNCBI Gene
Enables choline transmembrane transporter activity and ethanolamine transmembrane transporter activity. Involved in choline transport; ethanolamine transport; and transmembrane transport. Located in mitochondrial outer membrane and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
706 residues, UniProt reviewed canonical sequence.
>Q8IWA5|SLC44A2
1 MGDERPHYYG KHGTPQKYDP TFKGPIYNRG CTDIICCVFL LLAIVGYVAV GIIAWTHGDP
61 RKVIYPTDSR GEFCGQKGTK NENKPYLFYF NIVKCASPLV LLEFQCPTPQ ICVEKCPDRY
121 LTYLNARSSR DFEYYKQFCV PGFKNNKGVA EVLQDGDCPA VLIPSKPLAR RCFPAIHAYK
181 GVLMVGNETT YEDGHGSRKN ITDLVEGAKK ANGVLEARQL AMRIFEDYTV SWYWIIIGLV
241 IAMAMSLLFI ILLRFLAGIM VWVMIIMVIL VLGYGIFHCY MEYSRLRGEA GSDVSLVDLG
301 FQTDFRVYLH LRQTWLAFMI ILSILEVIII LLLIFLRKRI LIAIALIKEA SRAVGYVMCS
361 LLYPLVTFFL LCLCIAYWAS TAVFLSTSNE AVYKIFDDSP CPFTAKTCNP ETFPSSNESR
421 QCPNARCQFA FYGGESGYHR ALLGLQIFNA FMFFWLANFV LALGQVTLAG AFASYYWALR
481 KPDDLPAFPL FSAFGRALRY HTGSLAFGAL ILAIVQIIRV ILEYLDQRLK AAENKFAKCL
541 MTCLKCCFWC LEKFIKFLNR NAYIMIAIYG TNFCTSARNA FFLLMRNIIR VAVLDKVTDF
601 LFLLGKLLIV GSVGILAFFF FTHRIRIVQD TAPPLNYYWV PILTVIVGSY LIAHGFFSVY
661 GMCVDTLFLC FLEDLERNDG SAERPYFMSS TLKKLLNKTN KKAAESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC44A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 148 nTPM
Expression across tissuesHPA
Tissue
- placenta: 148 nTPM
- skeletal muscle: 137 nTPM
- blood vessel: 124 nTPM
- spleen: 109 nTPM
- stomach: 107 nTPM
- lung: 93 nTPM
Single-cell type
- platelets: 378 nCPM
- neutrophils: 356 nCPM
- extravillous trophoblasts: 356 nCPM
- migrating cytotrophoblasts: 270 nCPM
- early spermatids: 223 nCPM
- esophageal apical cells: 215 nCPM
Immune cell
- neutrophil: 485 nTPM
- non-classical monocyte: 280 nTPM
- eosinophil: 229 nTPM
- total PBMC: 147 nTPM
- basophil: 147 nTPM
- gdT-cell: 114 nTPM
Brain region
- medulla oblongata: 180 nTPM
- white matter: 169 nTPM
- spinal cord: 147 nTPM
- basal ganglia: 144 nTPM
- thalamus: 137 nTPM
- cerebellum: 133 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.98
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- choline transport
- ethanolamine transport
- phosphatidylcholine biosynthetic process
- positive regulation of canonical NF-kappaB signal transduction
- transmembrane transport
Molecular functions
- antiporter activity
- choline transmembrane transporter activity
- ethanolamine transmembrane transporter activity
- transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC44A2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC44A2 as an antibody target. Whether an autoantibody or antibody against SLC44A2 could matter depends on whether native SLC44A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC44A2 is annotated at the cell surface, where native SLC44A2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC44A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...